Kronos Bio, Inc. (KRON) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 57.07M |
| Enterprise Value | -2.6M |
| P/E Ratio | -0.62 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 5.45 |
| Price/Book Ratio | 0.6 |
| Enterprise/Revenue | -0.61 |
| Enterprise/EBITDA | 0.1 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
Profitability
| Profit Margin | -8.74 |
| Operating Margin | -9.43 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | -0.7 |
Income Statement
| Revenue | 9.85M |
| Revenue/Share | 0.16 |
| Gross Profit | 9.85M |
| EBITDA | -61.72M |
| Net Income | -86.08M |
| Diluted EPS | -1.43 |
Balance Sheet
| Total Cash | 99.73M |
| Total Cash/Share | 1.87 |
| Total Debt | 24.09M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 7.54 |
| Book Value Per Share | 1.46 |
Price History
| 52-Week Change | -29.6 |
| 52-Week High | 1.46 |
| 52-Week Low | 0.65 |
| Moving Average 50 Days | 0.8 |
| Moving Average 200 Days | 0.9 |
Statistics
| Average Volume | 855,959 |
| Shares Outstanding | 60.97M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
